ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use

MeSH terms

• Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
• Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
• Anti-Inflammatory Agents, Non-Steroidal / metabolism
• Aryl Hydrocarbon Hydroxylases / metabolism
• Aspirin / administration & dosage
• Aspirin / adverse effects
• Aspirin / metabolism
• Cardiovascular Diseases / drug therapy
• Clopidogrel
• Cytochrome P-450 CYP2C19
• Drug Interactions
• Drug Therapy, Combination
• Gastrointestinal Hemorrhage / chemically induced*
• Gastrointestinal Hemorrhage / prevention & control
• Histamine H2 Antagonists / administration & dosage*
• Histamine H2 Antagonists / adverse effects*
• Histamine H2 Antagonists / metabolism
• Humans
• Piperazines / administration & dosage
• Piperazines / adverse effects
• Piperazines / metabolism
• Platelet Aggregation Inhibitors / administration & dosage*
• Platelet Aggregation Inhibitors / adverse effects*
• Platelet Aggregation Inhibitors / metabolism
• Prasugrel Hydrochloride
• Proton Pump Inhibitors / administration & dosage*
• Proton Pump Inhibitors / adverse effects*
• Proton Pump Inhibitors / metabolism
• Purinergic P2Y Receptor Antagonists / administration & dosage*
• Purinergic P2Y Receptor Antagonists / adverse effects*
• Purinergic P2Y Receptor Antagonists / metabolism
• Risk Factors
• Thienopyridines / administration & dosage*
• Thienopyridines / adverse effects*
• Thienopyridines / metabolism
• Thiophenes / administration & dosage
• Thiophenes / adverse effects
• Thiophenes / metabolism
• Ticlopidine / administration & dosage
• Ticlopidine / adverse effects
• Ticlopidine / analogs & derivatives*
• Ticlopidine / metabolism